Indeed, among patients with NT-proBNP ≥ 400 pg/mL, the relationship between NT-proBNP and CV outcomes differs with lower absolute risk in AF patients in comparison with those who do not have any forms of AF [30]. The gene discussed is NPPB; the disease is atrial fibrillation.